Erytech Pharma | Mutual Funds
Mutual Funds that own Erytech Pharma
HBM BioVentures Ltd.
440,000
2.45%
100,000
0.32%
12/31/2017
Industria
418,817
2.34%
0
0.3%
05/31/2018
JPMorgan Funds - Global Healthcare Fund
210,901
1.18%
-61,740
0.08%
05/31/2018
Government Pension Fund - Global (The)
179,203
1%
49,999
0%
12/31/2017
Stichting Pensioenfonds ABP (Global Equity Portfolio)
117,647
0.66%
-11,440
0%
03/31/2018
Royance Sélection Internationale
68,497
0.38%
-5,389
3.31%
05/31/2018
Apus Capital Revalue Fonds
60,000
0.34%
20,000
0.35%
09/30/2017
Etoile Santé Europe
57,407
0.32%
0
0.31%
01/31/2018
Attila Global Opportunity Fund
30,327
0.17%
16,000
1.01%
12/31/2017
LBPAM Actions Santé
20,000
0.11%
0
0.14%
06/29/2018
| Address |
Bâtiment Adénine
Lyon Rhone-Alpes 69008
France
|
|
Employees
|
- |
| Website |
http://www.erytech.com |
| Updated |
07/08/2019 |
| ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. |
